Boehringer Ingelheim Cares Foundation Patient Assistance Program
Free BI diabetes meds (Jardiance / Synjardy / Glyxambi / Trijardy / Tradjenta / Jentadueto) for uninsured or Medicare Part D patients. 2026 income limit: ≤250% FPL = $39,900 single / $54,100 couple / $82,500 family of 4 (48 states; higher in AK/HI).
Doctor signature neededUninsured only
What you need to enroll
Your doctor needs to sign part of the application
This program requires a prescriber signature. The easiest path: download the application, bring it to your next appointment, and have the office fax it in for you.
Your copay
Free
Eligible patients pay $0. See the eligibility checklist below to confirm you qualify.
2026 income limits (Group 2 = all diabetes drugs, ≤250% FPL, 48 states): 1-person $39,900, 2-person $54,100, 3-person $68,300, 4-person $82,500, 5-person $96,700, 6-person $110,900. Alaska/Hawaii limits higher. SAME limit applies to uninsured AND Medicare Part D beneficiaries (this is a 2026 change — previously Medicare-only had stricter limits). All BI diabetes drugs are in Group 2. Group 1 (≤200% FPL) covers respiratory drugs only — not diabetes. NEW for 2026: previously grandfathered higher-income patients are removed from program effective 1/1/2026. Enrollment lasts 12 months from approval (Medicare Part D approved 10/15–12/31 lasts through 12/31 of following year, max 15 months). Document ID PC-US-148739 (1/2026).
Be first when we launch — we'll save these matches and remind you to renew.